3-(butylamino)-4-chloro-5-sulfamoylbenzoic acid
Modify Date: 2025-08-30 14:05:45
3-(butylamino)-4-chloro-5-sulfamoylbenzoic acid structure
|
Common Name | 3-(butylamino)-4-chloro-5-sulfamoylbenzoic acid | ||
|---|---|---|---|---|
| CAS Number | 22893-29-4 | Molecular Weight | 306.76600 | |
| Density | 1.448g/cm3 | Boiling Point | 565.1ºC at 760mmHg | |
| Molecular Formula | C11H15ClN2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 295.6ºC | |
| Name | 3-(butylamino)-4-chloro-5-sulfamoylbenzoic acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.448g/cm3 |
|---|---|
| Boiling Point | 565.1ºC at 760mmHg |
| Molecular Formula | C11H15ClN2O4S |
| Molecular Weight | 306.76600 |
| Flash Point | 295.6ºC |
| Exact Mass | 306.04400 |
| PSA | 117.87000 |
| LogP | 3.75170 |
| Vapour Pressure | 1.31E-13mmHg at 25°C |
| Index of Refraction | 1.599 |
| InChIKey | CNBZFYQGTRTWSM-UHFFFAOYSA-N |
| SMILES | CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Cl |
| HS Code | 2935009090 |
|---|
|
~%
3-(butylamino)-... CAS#:22893-29-4 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 123 ; WO 2012/018635 A2 |
|
~%
3-(butylamino)-... CAS#:22893-29-4 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2935009090 |
|---|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
| HH 562 |
| 3-butylamino-4-chloro-5-sulfamoyl-benzoic acid |
| N-Butyl-4-chloro-5-sulfamylmetanilic acid |
| N-n-Butyl-4-chlor-5-sulfamylmetanilsaeure |